Skip to main content
Select Search Option
Menu
Weill Cornell Medicine
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach

Wayfinder menu

  • News and Events
  • Directory
  • Cornell University Center for Technology Licensing
Enterprise Innovation
Enterprise Innovation
Explore this Website

Wayfinder menu

  • News and Events
  • Directory
  • Cornell University Center for Technology Licensing
  • Home
  • About Us
    • Leadership
    • Team Directory
    • Annual Reports
    • Career Opportunities
    • Contact Us
    • Support Us
  • For Inventors and Innovators
    • Learn About Our Process
    • Connect with Enterprise Innovation
    • Submit Disclosure to Center for Technology Licensing
    • Material Transfer Agreements
    • Inventor Portal
    • Forms and Policies
  • For Industry, Investors and Partners
    • Technology Portfolio
    • Collaboration Opportunities
    • About Our Startups
      • Our Startups
  • Innovation Ecosystem
    • BioVenture eLab
    • Center for Technology Licensing at Weill Cornell Medicine
    • Weill Cornell Medicine in Qatar (WCM-Q)
  • Programs, Offerings and Support
    • Intellectual Property
      • IP and Biotech Due Diligence Workshop
      • IP Series
    • Expertise and Mentorship
      • CEO Speaker Series
      • Cornell Innovation and Venture Advisors (CIVA)
      • Enterprise Innovation Departmental Liaisons
      • Entrepreneur-in-Residence (EiR) Program
      • Industry Mentors
      • Office Hours
      • Pitch Coaching
    • Credit Bearing Courses and Certificate Programs in Innovation and Entrepreneurship
      • Accelerating BioVenture Innovation (ABI)
      • BioEntrepreneurship Initiative
      • Fundamentals of Academic Business Development
    • Entrepreneurship and Startup Basics
      • Accelerating BioVenture Innovation (ABI)
      • Biomedical Innovation Challenge
      • Capstone Programs and Business Plan Support
      • I-Corps Entrepreneurship Training
      • New Ventures Series
      • Startup Symposium & InvestConnect
    • De-risking, Gap and Seed Funding Sources
      • Daedalus Fund for Innovation
      • Ignite Cornell Lab to Market
      • SBIR/STTR Grant Writing Resources
      • The Gene ’70, MD ’74 and Susan Resnick Prize for Excellence in Entrepreneurship
    • Research and Industry Collaboration Opportunities
    • Medical Device Initiatives
      • 3D Printer Interest Group
      • Computation and Medical Device Interest Group
    • General and Special Interests
      • CTL at Weill Cornell Special Healthcare Innovation Panels
      • Dean’s Symposium on Innovation
    • Diversity in Innovation and Entrepreneurship
      • Invent Together
      • LifeSci NYC Internship Program
    • Partnership in Innovation and Entrepreneurial Education
      • BioDesign Series – Engineering Summer Program (ESP)
      • Advancing Cornell Career Experiences for Science Students (ACCESS)
      • Eclectic Convergence, Cornell Entrepreneurship Summit
    • Learning Library
  • News and Events
    • Events
    • Past Events
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
  • Home
  • About Us
  • For Inventors and Innovators
  • For Industry, Investors and Partners
  • Innovation Ecosystem
  • Programs, Offerings and Support
  • News and Events
  • Home
  • For Industry, Investors and Partners
    • Technology Portfolio
    • Collaboration Opportunities
    • About Our Startups

Technology Portfolio

     

Generation of Glucose-Responsive Stomach Cells for the Treatment of Diabetes

Transient Modified-RNA Expression of Activation Factor Promotes Adult Hematopoietic Stem Cell Expansion

Multi-Purpose Hyper-Stable Fluorescent Proteins

Treatment of Fungal-Associated Irritable Bowel Disease Using IL-1 Inhibitors

Improved Epigenetic Signatures for Breast Cancer Prognosis and Treatment Selection

GoTChA: Genotyping of Targeted loci with single-cell Chromatin Accessibility

Customizable Skull Prosthesis for Protection Following Craniectomy

A Novel Adenovirus-based Vaccine for the Treatment of Fentanyl Addiction

Small Molecules that Protect Against Lipofuscin Toxicity to Prevent Blindness

3-HKA Analogs for the Treatment of Autoimmune Diseases

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
Our Location
Enterprise Innovation
Contact Us
  • Twitter
  • LinkedIn
Enterprise Innovation
1155 York Ave.
New York, NY 10065
Phone: (646) 962-7045
  • About Us
    • Leadership
    • Team Directory
    • Annual Reports
    • Career Opportunities
    • Contact Us
    • Support Us
  • For Inventors and Innovators
    • Learn About Our Process
    • Connect with Enterprise Innovation
    • Submit Disclosure to Center for Technology Licensing
    • Material Transfer Agreements
    • Inventor Portal
    • Forms and Policies
  • For Industry, Investors and Partners
    • Technology Portfolio
    • Collaboration Opportunities
    • About Our Startups
  • Innovation Ecosystem
    • BioVenture eLab
    • Center for Technology Licensing at Weill Cornell Medicine
    • Weill Cornell Medicine in Qatar (WCM-Q)
  • Programs, Offerings and Support
    • Intellectual Property
    • Expertise and Mentorship
    • Credit Bearing Courses and Certificate Programs in Innovation and Entrepreneurship
    • Entrepreneurship and Startup Basics
    • De-risking, Gap and Seed Funding Sources
    • Research and Industry Collaboration Opportunities
    • Medical Device Initiatives
    • General and Special Interests
    • Diversity in Innovation and Entrepreneurship
    • Partnership in Innovation and Entrepreneurial Education
    • Learning Library
  • News and Events
    • Events
    • Past Events
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine
© Weill Cornell Medicine.
  • Privacy & Legal
  • Careers
  • Giving
  • Directory
  • Web Accessibility Assistance